Analysts have maintained their price target for Commercial International Bank Egypt (CIB) at EGP 128.65, citing a steady financial outlook and only minor adjustments in key valuation metrics.
What's in the News
- CIB will communicate its new 5-year strategic plan to investors and analysts during an upcoming Analyst/Investor Day (Key Developments)
- Approval has been granted to amend Articles "6" and "7" of the Bank's Statute, reflecting internal changes to the bank's bylaws (Key Developments)
- A Special/Extraordinary Shareholders Meeting is scheduled for September 25, 2025, at the bank's headquarters in Giza, Egypt (Key Developments)
- A proposal to increase issued capital and authorize key legal personnel to formalize statute amendments will be presented at the Ordinary General Assembly on September 25, 2025 (Key Developments)
Valuation Changes
- Consensus Analyst Price Target remains unchanged at EGP 128.65.
- Discount Rate has risen slightly from 31.91% to 31.93%.
- Revenue Growth estimate is virtually unchanged at 9.88%.
- Net Profit Margin is stable at approximately 52.44%.
- Future P/E multiple has increased marginally from 11.55x to 11.55x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.